These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 28941492)
1. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo. Le Poole IC; Mehrotra S J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S38-S45. PubMed ID: 28941492 [TBL] [Abstract][Full Text] [Related]
2. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358 [TBL] [Abstract][Full Text] [Related]
3. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation. Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752 [TBL] [Abstract][Full Text] [Related]
4. Reduced skin homing by functional Treg in vitiligo. Klarquist J; Denman CJ; Hernandez C; Wainwright DA; Strickland FM; Overbeck A; Mehrotra S; Nishimura MI; Le Poole IC Pigment Cell Melanoma Res; 2010 Apr; 23(2):276-86. PubMed ID: 20175879 [TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo. Essien KI; Katz EL; Strassner JP; Harris JE J Invest Dermatol; 2022 Dec; 142(12):3158-3166.e7. PubMed ID: 35777498 [TBL] [Abstract][Full Text] [Related]
6. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Mukhatayev Z; Dellacecca ER; Cosgrove C; Shivde R; Jaishankar D; Pontarolo-Maag K; Eby JM; Henning SW; Ostapchuk YO; Cedercreutz K; Issanov A; Mehrotra S; Overbeck A; Junghans RP; Leventhal JR; Le Poole IC Front Immunol; 2020; 11():581433. PubMed ID: 33335528 [TBL] [Abstract][Full Text] [Related]
7. A quantitative increase in regulatory T cells controls development of vitiligo. Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614 [TBL] [Abstract][Full Text] [Related]
8. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin. Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin. Miao X; Xu R; Fan B; Chen J; Li X; Mao W; Hua S; Li B Sci Rep; 2018 Jan; 8(1):1605. PubMed ID: 29371688 [TBL] [Abstract][Full Text] [Related]
11. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532 [TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics. Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells. Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433 [TBL] [Abstract][Full Text] [Related]
15. Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance. Chen J; Wang X; Cui T; Ni Q; Zhang Q; Zou D; He K; Wu W; Ma J; Wang Y; Guo W; Li C; Li S J Autoimmun; 2022 Jul; 131():102859. PubMed ID: 35792518 [TBL] [Abstract][Full Text] [Related]
16. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo. Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998 [TBL] [Abstract][Full Text] [Related]
17. Umbilical cord blood‑derived Helios‑positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway. Li X; Li D; Shi Q; Huang X; Ju X Mol Med Rep; 2019 May; 19(5):4195-4204. PubMed ID: 30896872 [TBL] [Abstract][Full Text] [Related]
18. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis. Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP J Bone Miner Res; 2015 Mar; 30(3):412-22. PubMed ID: 25264308 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune aspects of depigmentation in vitiligo. Le Poole IC; Wañkowicz-Kaliñska A; van den Wijngaard RM; Nickoloff BJ; Das PK J Investig Dermatol Symp Proc; 2004 Jan; 9(1):68-72. PubMed ID: 14870989 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses. Terras S; Gambichler T; Moritz RK; Altmeyer P; Lambert J Int J Dermatol; 2014 Mar; 53(3):294-9. PubMed ID: 23968190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]